Detalles de la búsqueda
1.
Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease.
Clin Gastroenterol Hepatol
; 21(13): 3314-3321.e3, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37149016
2.
The Predictive Role of Extracellular NAPRT for the Detection of Advanced Fibrosis in Biopsy-Proven Non-Alcoholic Fatty Liver Disease.
Int J Mol Sci
; 24(2)2023 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36674688
3.
Diagnostic scores and scales for appraising Nonalcoholic fatty liver disease and omics perspectives for precision medicine.
Curr Opin Clin Nutr Metab Care
; 25(5): 285-291, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35788123
4.
Effects of two personalized dietary strategies during a 2-year intervention in subjects with nonalcoholic fatty liver disease: A randomized trial.
Liver Int
; 41(7): 1532-1544, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33550706
5.
Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) Study.
Eur J Nutr
; 60(6): 3043-3057, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33474638
6.
Alcohol Drinking Impacts on Adiposity and Steatotic Liver Disease: Concurrent Effects on Metabolic Pathways and Cardiovascular Risks.
Curr Obes Rep
; 2024 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38520634
7.
Fecal and Circulating Biomarkers for the Non-Invasive Assessment of Intestinal Permeability.
Diagnostics (Basel)
; 13(11)2023 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37296827
8.
Impact of Chronotype and Mediterranean Diet on the Risk of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
Nutrients
; 15(14)2023 Jul 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37513675
9.
Impact of Health Related QoL and Mediterranean Diet on Liver Fibrosis in Patients with NAFLD.
Nutrients
; 15(13)2023 Jul 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37447344
10.
Prebiotics targeting gut-liver axis to treat non-alcoholic fatty liver disease.
Minerva Gastroenterol (Torino)
; 2023 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36892817
11.
A nutrigenetic precision approach for the management of non-alcoholic fatty liver disease.
Clin Nutr
; 42(11): 2181-2187, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37788561
12.
The Histology-Driven Differential Diagnosis in Bowel Inflammatory Conditions Is Not All That Obvious: Evidence from a Survey Based on Digital Slides.
Diagnostics (Basel)
; 13(24)2023 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38132268
13.
Cross-Sectional and Longitudinal Performance of Non-Invasive Tests of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
J Clin Med
; 12(2)2023 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36675579
14.
Prognostic Value of Simple Non-Invasive Tests for the Risk Stratification of Incident Hepatocellular Carcinoma in Cirrhotic Individuals with Non-Alcoholic Fatty Liver Disease.
Cancers (Basel)
; 15(6)2023 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36980543
15.
Role of Circadian Clock on the Pathogenesis and Lifestyle Management in Non-Alcoholic Fatty Liver Disease.
Nutrients
; 14(23)2022 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36501083
16.
Changes in Liver Stiffness and Markers of Liver Synthesis and Portal Hypertension following Hepatitis C Virus Eradication in Cirrhotic Individuals.
Biology (Basel)
; 11(8)2022 Aug 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36009789
17.
Interactive Role of Surrogate Liver Fibrosis Assessment and Insulin Resistance on the Incidence of Major Cardiovascular Events.
J Clin Med
; 11(17)2022 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36079118
18.
Neck Circumference for NAFLD Assessment during a 2-Year Nutritional Intervention: The FLiO Study.
Nutrients
; 14(23)2022 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36501189
19.
A nutrigenetic tool for precision dietary management of non-alcoholic fatty liver disease deeming insulin resistance markers.
Panminerva Med
; 64(4): 485-496, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35437302
20.
Morbid liver manifestations are intrinsically bound to metabolic syndrome and nutrient intake based on a machine-learning cluster analysis.
Front Endocrinol (Lausanne)
; 13: 936956, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36147576